Reduced and Delayed Cerebrovascular Reactivity in Patients with Parkinson's Disease

BackgroundCerebrovascular dysfunction in Parkinson's disease (PD) is heterogeneous and may contribute to disease pathophysiology or progression. There is a need to understand the mechanisms by which cerebrovascular dysfunction is altered in participants with PD. ObjectivesThe objective of this study is to test the hypothesis that participants with PD exhibit a significant reduction in the ability of the cerebral vessels to dilate in response to vasoactive challenges relative to healthy controls (HC). MethodsThe current study uses a vasodilatory challenge while participants undergo functional magnetic resonance imaging to quantify the amplitude and delay of cerebrovascular reactivity in participants with PD relative to age and sex-matched HC. An analysis of covariance was used to evaluate differences in cerebrovascular reactivity amplitude and latency between PD participants and HC. ResultsA significant main effect of group was observed for whole-brain cerebrovascular reactivity amplitude (F-(1,F- 28) = 4.38, p = 0.046, Hedge's g = 0.73) and latency (F-(1,F- 28) = 16.35, p < 0.001, Hedge's g = 1.42). Participants with PD exhibited reduced whole-brain amplitude and increased latencies in cerebrovascular reactivity relative to HC. The evaluation of regional effects indicates that the largest effects were observed in the cuneus, precuneus, and parietal regions. ConclusionsPD participants exhibited reduced and delayed cerebrovascular reactivity. This dysfunction may play an important role in chronic hypoxia, neuroinflammation, and protein aggregation, mechanisms that could lead to disease progression. Cerebrovascular reactivity may serve as an important biomarker and target for future interventions. (c) 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Automated summary

This study aimed to investigate cerebrovascular dysfunction in participants with Parkinson's disease (PD) compared to healthy controls (HC) using functional magnetic resonance imaging (fMRI) and vasodilatory challenges. The results showed that PD participants had reduced and delayed cerebrovascular reactivity, which may be associated with chronic hypoxia, neuroinflammation, and protein aggregation. Cerebrovascular reactivity may serve as an important biomarker and target for future interventions in PD.